Related Experiment Videos
[Prognostic value of cytofluorometry in bladder tumors]
Annales D'Urologie
|January 1, 1986
Summary
Flow cytometry (FCM) of bladder lavage fluid aids in diagnosing transitional cell carcinoma and assessing disease progression. This method evaluates DNA content to identify high-risk patients and monitor treatment effectiveness.
Area of Science:
- Uro-oncology
- Molecular diagnostics
- Cellular biology
Context:
- Transitional cell carcinoma (TCC) diagnosis and prognosis remain challenging.
- Accurate assessment of bladder cancer's evolutive potential is crucial for patient management.
- Current diagnostic methods may not fully capture the risk of disease progression.
Purpose:
- To evaluate the utility of flow cytometry (FCM) in analyzing bladder lavage fluid for TCC.
- To determine FCM's effectiveness in assessing DNA content for diagnostic and prognostic value.
- To explore FCM's role in monitoring endovesical chemotherapy.
Summary:
- Flow cytometry (FCM) was used to examine bladder lavage fluid in 112 patients with TCC.
- FCM analyzes epithelial cell DNA content, detecting tumorous diploid or aneuploid cells.
- Diagnostic sensitivity of FCM is comparable to cytology, but it offers prognostic insights via DNA index measurement.
Impact:
- FCM provides a more accurate evaluation of bladder disease potential, including dysplasia and carcinoma in situ.
- Tumor ploidy measured by FCM, particularly DNA index, has prognostic significance for recurrence.
- FCM's aneuploidy index measurement can monitor the effectiveness of endovesical chemotherapy.